BSHC
PFE icon

Breed's Hill Capital’s Pfizer PFE Stock Holding History

Breed's Hill Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$244K Sell
10,061
-152
-1% -$3.54K 0.12% 113
2025
Q1 		$259K Sell
10,213
-375
-4% -$9.81K 0.14% 103
2024
Q4 		$281K Buy
10,588
+2,533
+31% +$68.7K 0.15% 100
2024
Q3 		$233K Hold
8,055
– – 0.19% 91
2024
Q2 		$225K Buy
8,055
+557
+7% +$15.3K 0.2% 82
2024
Q1 		$208K Sell
7,498
-3
-0% -$83 0.19% 89
2023
Q4 		$216K Buy
+7,501
New +$227K 0.21% 82

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Breed's Hill Capital's PFE Position: Q2 2025 in Review

Breed's Hill Capital reduced its Pfizer (PFE) stake by 1.5% in Q2 2025, selling an estimated $3.54K and leaving 10,061 shares worth $244K. The position accounts for 0.12% of the portfolio, ranked #113.

Breed's Hill Capital first reported a position in PFE in Q4 2023 and has held it in 7 quarters since. The position peaked at $281K in Q4 2024. 2,813 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Breed's Hill Capital held 10,061 shares of Pfizer worth $244K as of Q2 2025.
  • Breed's Hill Capital sold 152 Pfizer shares in Q2 2025, an estimated $3.54K.
  • Pfizer made up 0.12% of Breed's Hill Capital's portfolio in Q2 2025, its #113 holding.
  • Breed's Hill Capital first reported a position in Pfizer in Q4 2023 and has held it in 7 quarters since.
  • Breed's Hill Capital's Pfizer position peaked at $281K in Q4 2024.
  • 2,813 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Breed's Hill Capital's 13F filing for Q2 2025, filed 8 Aug 2025.